肝胆相照论坛

标题: 现在是个医院好像都能看这个病，至于有没有效果，看你的 [打印本页]

作者: baixing3721 时间: 2011-10-28 20:08 标题: 现在是个医院好像都能看这个病，至于有没有效果，看你的

本帖最后由风雨不动于 2012-4-14 10:36 编辑

现在是个医院好像都能看这个病，至于有没有效果，看你的造化了

(6.合.彩)足球/篮球...各类投注开户下注

第一投注现金网:招代理/年薪10万以上:6668.cc

作者: wfavorz 时间: 2011-10-28 20:28

是啊。所以我从来不指望中国能研制出真正治好乙肝的药。因为这里面的利益群体太多了。你研制成功乙肝病人都好了，这些人还怎么赚钱？

作者: baixing3721 时间: 2011-10-28 22:14

你看人家古巴，虽然穷了点，但是全面免费医疗，免费教育，但是说实话，我宁愿我们国家穷点，吃的穿的差点，也要体现一下优越性。

作者: maodaxian 时间: 2011-10-28 22:32

我国将处于并将长期处于社会主义的初级阶段，最终实现共产主义，资本主义是万恶的，是站不住脚的。

作者: kk980102 时间: 2011-10-28 22:44

人家的资本主义是腐而不朽的，垂而不死的

作者: kk980102 时间: 2011-10-28 22:44

就那么几种药，就看谁用的更好一些，

作者: ⑤⑥⑦ 时间: 2011-10-28 23:50

作者: MiddleAgeMan 时间: 2011-10-29 00:55

If you are about to use antiviral medicine. do not start with LAM. REPEAT, DO NOT START WITH LAM.

It is best to start with enticavir.

Dan

作者: lovecloudy 时间: 2011-10-29 04:31

MiddleAgeMan 发表于 2011-10-29 00:55
If you are about to use antiviral medicine. do not start with LAM. REPEAT, DO NOT START WITH LAM.

I ...

why you always recommend enticavir ,
could you explain more?
merci !

作者: MiddleAgeMan 时间: 2011-10-29 04:52

To: lovecloudy

From:

Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY
GASTROENTEROLOGY 2009;137:1593–1608

Authors: FABIEN ZOULIM*,‡,§ and STEPHEN LOCARNINI
*INSERM, U871, Lyon; ‡Université Lyon 1, Lyon; §Hospices Civils de Lyon, Service d’hépatologie et de gastroentérologie, Lyon, France; and Victorian Infectious
Diseases Reference Laboratory, North Melbourne, Victoria, Australia

Lamivudine resistance: 23% (1year) to 80%(5 year)
entecavir(naive) resistance: 0.2%(1 year) to 1.2% (6 year)
Entecavir (LAM resistant): 6%(1 year), 15%(2 years) to 51%(5 years)
tenofovir resistance: 0% (1year) to 0% (2 year)

Because drug-resistant mutant HBV populations are
established and expand through replication, antiviral
therapy, once initiated, should aim to suppress viral replication
as completely and rapidly as possible. The lower
risk of resistance to TDF and ETV (compared with LMV,
LdT, and ADV) supports their use as first-line therapy,

Since tenofovir is not available in China at this time, entecavir should be used as first line antiviral medicine.

This is the reason I am so against Dr. 王震宇 who is still advocating LAM as first choice to treat HBVer.

Dan

作者: 同肝共哭123 时间: 2011-10-29 09:13

回复 MiddleAgeMan 的帖子

欢迎光临肝胆相照论坛 (http://hbvhbv.info/forum/)